ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

ONS Again Offers Nursing Certification Exam In May, Sept

January 11, 1991

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005